Home / BusinessCNBCBusinessCNBC·Jul 22, 2026·1 min readWall Street can wait: Why one U.S. biotech firm is listing in Hong Kong firstGlobal biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese pharmaceutical partners.View original source — CNBC ↗ShareCopy linkShare on XShare on FacebookRelated storiesThe PunchBusinessJul 22, 2026 · 1 minJoshua motivated to continue boxing, says HearnThe PunchThe PunchBusinessJul 22, 2026 · 1 minFinancial stability remains foundation for growth – OyedeleThe PunchBloombergBusinessJul 22, 2026 · 1 minRising Crude, US Rate-Hike Bets Counter Dollar Inflow Support for RupeeBloombergCNABusinessJul 22, 2026 · 1 minJapan imports jump to record high on oil price surge, complicating BOJ policyCNA
The PunchBusinessJul 22, 2026 · 1 minFinancial stability remains foundation for growth – OyedeleThe Punch
BloombergBusinessJul 22, 2026 · 1 minRising Crude, US Rate-Hike Bets Counter Dollar Inflow Support for RupeeBloomberg
CNABusinessJul 22, 2026 · 1 minJapan imports jump to record high on oil price surge, complicating BOJ policyCNA